| Cat. No. | Product Name | Field of Application | Chemical Structure |
|---|---|---|---|
| DCC3983 | pal-287 | Full DAT/5-HT transporter substrate; Non-neurotoxic releasing agent of serotonin, norepinephrine, and dopamine; Full agonist at 5-HT2B and partial agonist at 5-HT2C |
|
| DCC3984 | Pal-545 Hydrochloride | Potent dual dopamine-serotonin (DA/5-HT) releaser |
|
| DCC3985 | Palbociclib Dihydrochloride Featured | Selective inhibitor of the cyclin-dependent kinases CDK4 and CDK6 |
|
| DCC3986 | Palmostatin M | Novel Ras-Signaling Modulator, targeting acyl protein thioesterase 1 (APT1) and 2 (APT2) in cells |
|
| DCC3987 | Palonosetron | Potent serotonin-3 (5-HT3) receptor antagonist |
|
| DCC3988 | Pam2cys | Novel TLR2 agonist as potential adjuvant for cancer vaccines |
|
| DCC3989 | Pancratistatin | Inhibitor of the Cell_cycle>cell cycle from G0/G1 to S phase with powerful antiparasite activity |
|
| DCC3990 | Panduratin A | Biological Active Reagents |
|
| DCC3991 | panomifene | Tamoxifen analogue; antiestrogenic |
|
| DCC3992 | Pan-raf/rtk Inhibitor I-16 | Novel potent pan-Raf and receptor tyrosine kinase inhibitor, potently inhibits all subtypes of Rafs with IC50 values of 3.49 (BRafV600E), 8.86 (ARaf), 5.78 (BRafWT), and 1.65 nM (CRaf), respectively |
|
| DCC3993 | Pao-pdt | Potent and highly selective small molecule inhibitor of thioredoxin reductase (TrxR) |
|
| DCC3994 | Pape-1 | Pathway Preferential Estrogen, activating the extranuclear signaling pathway without activity on the nuclear signaling pathway |
|
| DCC3996 | Para-aminoblebbistatin | Blebbistatin derivative, increasing water solubility, decreases the inherent fluorescence, stabilizing the molecule to circumvent its degradation by prolonged blue light exposure, and decreasing its phototoxicity while retaining the in vitro and in vivo a |
|
| DCC3997 | Para-cid-5951923 | Isomer of CID-5951923 |
|
| DCC3998 | Para-nitroblebbistatin | Selective cell-permeable inhibitor of non-muscle myosin II ATPases, being more stable and less phototoxic than Blebbistatin |
|
| DCC3999 | Paraoxon | Acetylcholinesterase inhibitor, the active metabolite of the insecticide parathion |
|
| DCC4000 | Paraquat Diiodide | Non-selective contact herbicide, killing green plant tissue on contact, being highly toxic and linked to Parkinson's disease, generating reactive oxygen species (ROS), which causes cell death and potentially leading to acute respiratory distress syndrome |
|
| DCC4001 | Parogrelil | Novel potent phosphodiesterase 3 inhibitor, suppressing the asthmatic response and showing both bronchodilating and anti-inflammatory effects |
|
| DCC4002 | Parogrelil Hydrochloride | Novel potent phosphodiesterase 3 inhibitor, suppressing the asthmatic response and showing both bronchodilating and anti-inflammatory effects |
|
| DCC4003 | Parp/brd4 Inhibitor Iii-16 | Potent and Novel Dual PARP/BRD4 Inhibitor for Efficient Treatment of Pancreatic Cancer |
|
| DCC4004 | Parp1/brd4 Inhibitor Iii-7 | Novel highly selective dual PARP1/BRD4 inhibitor (PARP1 IC 50 =49nM; BRD4 IC 50 =202nM), repressing the expression and activity of PARP1 and BRD4 to synergistically inhibit the malignant growth of pancreatic cancer cells in vitro and in vivo |
|
| DCC4005 | Parp10-in-22 | Novel Selective Cell-Active Inhibitor of PARP10 |
|
| DCC4006 | Parpi-fl | Fluorescent PARP1 Inhibitor for Glioblastoma Imaging |
|
| DCC4007 | Parvifoline Aa | Natural ent-kaurane diterpenoid, markedly stimulates the expression of NKG2D ligands on hepatocellular carcinoma (HCC) cells, considerably enhancing their recognition and lysis by NK cells, covalently inhibiting peroxiredoxins I/II (Prxs-I/II) catalytic a |
|
| DCC4008 | Pav-866 | Novel antiviral agent, potently against Rabies virus (RABV) targeting host-rabies virus protein-protein interactions |
|
| DCC4009 | Pazinaclone | Partial agonist at GABAA benzodiazepine receptors with sedative and anxiolytic effects |
|
| DCC4010 | pbdnj0802 | Novel potent inhibitor of |
|
| DCC4011 | pbdnj0804 | Novel potent glucosidase inhibitor, suppressing HCV virion assembly and secretion, potently inhibiting DENV infection in vitro |
|
| DCC4012 | Pbi.105 | Novel Inhibitor of Parasite Proliferation of Asexual Blood Stage P. falciparum Parasites |
|
| DCC4013 | Pbi.120 | Novel Inhibitor of Parasite Proliferation of Asexual Blood Stage P. falciparum Parasites |
|
